Related Experiment Video
Updated: Aug 14, 2025

09:03
Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye
Published on: June 20, 2015
10.1K
Characterization of Trabecular Meshwork Mechanical Property Modulation After Application of Lipids
Wyndham Batchelor1, Jennifer Arcuri2, Sanjoy K Bhattacharya2
1Biomedical Atomic Force Microscopy Laboratory, Department of Biomedical Engineering, University of Miami College of Engineering, Miami, FL, USA.
Methods in Molecular Biology (Clifton, N.J.)
|January 18, 2023
Summary
Treating eye lipids may slow glaucoma progression. This study details a method to alter trabecular meshwork stiffness using lipids in vitro.
Area of Science:
- Ophthalmology
- Biomedical Engineering
- Biochemistry
Background:
- Glaucoma is a leading cause of irreversible blindness.
- Elevated intraocular pressure is a primary risk factor for glaucoma.
- The trabecular meshwork (TM) plays a crucial role in regulating aqueous humor outflow and intraocular pressure.
Purpose of the Study:
- To investigate the potential of targeting endogenous lipids in the aqueous humor as a therapeutic strategy for glaucoma.
- To develop and characterize a method for treating trabecular meshwork (TM) samples in vitro with specific lipids.
- To assess the impact of lipid treatment on the biomechanical properties, specifically stiffness, of TM tissues.
Main Methods:
- Isolation and preparation of human trabecular meshwork (TM) samples.
- In vitro incubation of TM samples with defined lipid formulations.
- Quantification of lipid composition within TM tissues.
- Measurement of TM sample stiffness using atomic force microscopy (AFM) or similar biomechanical testing techniques.
Main Results:
- Lipid treatment significantly altered the stiffness of the trabecular meshwork (TM) samples.
- Characterization revealed specific changes in lipid profiles within the treated TM tissues.
- The study established a reproducible method for lipid-based modulation of TM biomechanics.
Conclusions:
- Targeting aqueous humor lipids presents a novel therapeutic avenue for glaucoma management.
- Modulating TM stiffness via lipid treatment may offer a new approach to controlling intraocular pressure.
- Further research is warranted to translate these in vitro findings into clinical applications for glaucoma therapy.

